Regulatory affairs support. September 22, 2017 - september 21, 2022. N01DA-17-8933.

Ended Definitive Contract Awarded Last action

Contract number
HHSN271201700070C
Awardee
Awarding agency
Obligated
$273,577

Award facts

Opportunity
Contract value 100% obligated
$273,577.07 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 4 offers Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
San Jose, CA 95110, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00013 -$193,216
Funding Only Action P00012 -$1,370
Funding Only Action P00011 -$99,839
Funding Only Action P00010 · Regulatory affairs support $124,740
Other Administrative Action P00009 $0
Other Administrative Action P00008 $0
Funding Only Action P00007 -$24,120
Other Administrative Action P00006 · September 21, 2022. N01DA-17-8933. $0
Funding Only Action P00005 $71,949
Funding Only Action P00004 $47,608
Funding Only Action P00003 · Purpose: to obligate funds to fully fund performance under task order no. 04 and update sections b and g of the contract. Contract amount: not to exceed… $83,068
Funding Only Action P00002 $47,004
Exercise an Option 1 $120,520
Original award $97,233
Show all 14

About this award

Written by GovTribe AI ·

This is a five-year, $273,577.07 cost-plus-fixed-fee contract awarded by the National Institute on Drug Abuse (NIDA) to CCS Associates, Inc., a woman-owned small business. The contract provides regulatory affairs support services, including preparing and filing regulatory submissions such as Investigational New Drug (IND) applications and New Drug Applications (NDAs) for NIDA's drug development initiatives across areas like addiction, neurological disorders, and rare diseases. This contract is a competitive renewal of a previous NIDA regulatory support contract and is designated as a total small business set-aside. CCS Associates holds several significant indefinite delivery/indefinite quantity (IDIQ) contracts with NIDA, the National Center for Advancing Translational Sciences, and the National Institute of Allergy and Infectious Diseases to rapidly provide a broad range of research and regulatory services to support the agencies' medical research and drug development programs.

Quick answers

Who was awarded contract HHSN271201700070C?

HHSN271201700070C was awarded to CCS Associates, Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 22, 2017.

How much is contract HHSN271201700070C worth?

The government has obligated $273,577 on HHSN271201700070C.

Was contract HHSN271201700070C competed?

The extent of competition for HHSN271201700070C was full and open competition after exclusion of sources. The government received 4 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login